Wechselwirkungen von Cefixim

AMOXIL is contraindicated in patients who have experienced a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to AMOXIL or to other β-lactam antibacterial drugs (e.g., penicillins and cephalosporins). (Fachinformation zu Amoxicillin, Gegenanzeigen)

History of a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to AUGMENTIN or to other beta‑lactams (e.g., penicillins or cephalosporins). (Fachinformation zu Amoxicillin und Clavulansäure, Gegenanzeigen)

CONTRAINDICATIONS The use of Ampicillin is contraindicated in individuals with a history of serious hypersensitivity reactions (e.g., anaphylaxis or Stevens-Johnson syndrome) to ampicillin or to other beta-lactam antibacterial drugs. (Fachinformation zu Ampicillin, Gegenanzeigen)

CONTRAINDICATIONS The use of UNASYN is contraindicated in individuals with a history of serious hypersensitivity reactions (e.g., anaphylaxis or Stevens-Johnson syndrome) to ampicillin, sulbactam or to other beta-lactam antibacterial drugs (e.g., penicillins and cephalosporins). (Fachinformation zu Ampicillin und Sulbactam, Gegenanzeigen)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (Fachinformation zu Cefixim, Gegenanzeigen)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (Fachinformation zu Cefixim, Gegenanzeigen)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (Fachinformation zu Cefixim, Gegenanzeigen)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (Fachinformation zu Cefixim, Gegenanzeigen)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (Fachinformation zu Cefixim, Gegenanzeigen)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (Fachinformation zu Cefixim, Gegenanzeigen)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (Fachinformation zu Cefixim, Gegenanzeigen)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (Fachinformation zu Cefixim, Gegenanzeigen)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (Fachinformation zu Cefixim, Gegenanzeigen)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (Fachinformation zu Cefixim, Gegenanzeigen)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (Fachinformation zu Cefixim, Gegenanzeigen)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (Fachinformation zu Cefixim, Gegenanzeigen)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (Fachinformation zu Cefixim, Gegenanzeigen)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (Fachinformation zu Cefixim, Gegenanzeigen)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (Fachinformation zu Cefixim, Gegenanzeigen)

INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (Fachinformation zu Ertapenem, Gegenanzeigen)

Hypersensitivity Reactions: Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving therapy with beta-lactams. (Fachinformation zu Imipenem und Cilastatin, Warnhinweise und Vorsichtsmaßnahmen)

WARNINGS Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving beta-lactam antibacterial drugs. (Fachinformation zu Nafcillin, Warnhinweise)

Piperacillin and Tazobactam for Injection and Sodium Chloride Injection is contraindicated in patients with a history of allergic reactions to any of the penicillins, cephalosporins, or betalactamase inhibitors. (Fachinformation zu Piperacillin und Tazobactam, Gegenanzeigen)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (Fachinformation zu Cefixim, Warnhinweise und Vorsichtsmaßnahmen)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (Fachinformation zu Cefixim, Warnhinweise und Vorsichtsmaßnahmen)

Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Fachinformation zu Aztreonam, Warnhinweise und Vorsichtsmaßnahmen)

If this product is to be given to penicillin-sensitive patients, caution should be exercised because cross hypersensitivity among beta-lactam antibacterial drugs has been clearly documented and may occur in up to 10% of patients with a history of penicillin allergy. (Fachinformation zu Cefixim, Warnhinweise und Vorsichtsmaßnahmen)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (Fachinformation zu Cefixim, Warnhinweise und Vorsichtsmaßnahmen)

Drug monitoring may be of assistance in detecting alterations in carbamazepine plasma concentrations. (Fachinformation zu Cefixim, Arzneimittelwechselwirkungen)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (Fachinformation zu Cefixim, Warnhinweise und Vorsichtsmaßnahmen)

If this product is to be given to penicillin-sensitive patients, caution should be exercised because cross hypersensitivity among beta-lactam antibacterial drugs has been clearly documented and may occur in up to 10% of patients with a history of penicillin allergy. (Fachinformation zu Cefixim, Warnhinweise und Vorsichtsmaßnahmen)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (Fachinformation zu Cefixim, Warnhinweise und Vorsichtsmaßnahmen)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (Fachinformation zu Cefixim, Warnhinweise und Vorsichtsmaßnahmen)

Ethacrynic acid may increase the ototoxic potential of other drugs such as aminoglycoside and some cephalosporin antibiotics. (Fachinformation zu Etacrynsäure, Arzneimittelwechselwirkungen)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (Fachinformation zu Cefixim, Warnhinweise und Vorsichtsmaßnahmen)

Cephalosporin Furosemide can increase the risk of cephalosporin-induced nephrotoxicity even in the setting of minor or transient renal impairment. (Fachinformation zu Furosemid, Arzneimittelwechselwirkungen)

Increased nephrotoxicity has been reported following concomitant administration of aminoglycoside antibiotics and cephalosporins. (Fachinformation zu Gentamicin, Arzneimittelwechselwirkungen)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (Fachinformation zu Cefixim, Warnhinweise und Vorsichtsmaßnahmen)

Examples Cyclosporine A, trimethoprim/sulfamethoxazole, bile acid sequestrants (cholestyramine), rifampin as well as aminoglycoside, cephalosporin, fluoroquinolone and penicillin classes of antimicrobials Drugs Modulating Glucuronidation Clinical Impact Concomitant use with drugs inducing glucuronidation decreases MPA systemic exposure, potentially reducing mycophenolate… (Fachinformation zu Mycophenolat, Arzneimittelwechselwirkungen)

If this product is to be given to penicillin-sensitive patients, caution should be exercised because cross hypersensitivity among beta-lactam antibacterial drugs has been clearly documented and may occur in up to 10% of patients with a history of penicillin allergy. (Fachinformation zu Cefixim, Warnhinweise und Vorsichtsmaßnahmen)

If this product is to be given to penicillin-sensitive patients, caution should be exercised because cross hypersensitivity among beta-lactam antibacterial drugs has been clearly documented and may occur in up to 10% of patients with a history of penicillin allergy. (Fachinformation zu Cefixim, Warnhinweise und Vorsichtsmaßnahmen)

Prothrombin time should be monitored in patients at risk and exogenous vitamin K administered as indicated. (Fachinformation zu Cefixim, Warnhinweise und Vorsichtsmaßnahmen)

Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (Fachinformation zu Probenecid, Arzneimittelwechselwirkungen)

DRUG INTERACTIONS When probenecid is used to elevate plasma concentrations of penicillin, or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (Fachinformation zu Probenecid und Colchicin, Arzneimittelwechselwirkungen)

Drug Interactions Protamine sulfate has been shown to be incompatible with certain antibiotics, including several of the cephalosporins and penicillins (see DOSAGE AND ADMINISTRATION ). (Fachinformation zu Protamin, Vorsichtsmaßnahmen)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (Fachinformation zu Cefixim, Warnhinweise und Vorsichtsmaßnahmen)

Prothrombin time should be monitored in patients at risk and exogenous vitamin K administered as indicated. (Fachinformation zu Cefixim, Warnhinweise und Vorsichtsmaßnahmen)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (Fachinformation zu Cefixim, Warnhinweise und Vorsichtsmaßnahmen)

Before initiating therapy with Meropenem for injection, it is important to inquire about previous hypersensitivity reactions to penicillins, cephalosporins, other β-lactams, and other allergens. (Fachinformation zu Meropenem, Warnhinweise und Vorsichtsmaßnahmen)

Drug/Laboratory Test Interactions A false-positive reaction for ketones in the urine may occur with tests using nitroprusside but not with those using nitroferricyanide. (Fachinformation zu Cefixim, Arzneimittelwechselwirkungen)